nucleic
acid
amplif
test
nat
increasingli
use
diagnosi
respiratori
viru
infect
familiar
format
use
dna
rna
target
amplif
method
enhanc
sensit
cultur
antigenbas
procedur
although
gel
platehybridis
method
still
utilis
analysi
amplifi
product
detect
use
realtim
method
requir
handl
amplifi
product
favour
mani
laboratori
assay
base
nucleic
acid
amplif
detect
design
broad
rang
respiratori
virus
particularli
use
detect
recent
identifi
virus
human
metapneumoviru
coronavirus
howev
wide
rang
potenti
pathogen
caus
similar
respiratori
symptomolog
diseas
make
applic
individu
diagnost
assay
base
detect
dna
rna
complex
expens
one
way
resolv
potenti
problem
undertak
multiplex
nucleic
acid
amplif
reaction
analysi
amplifi
product
suspens
microarray
respiratori
viru
panel
rvp
luminex
molecular
diagnost
one
exampl
approach
could
made
avail
diagnost
public
health
laboratori
broad
spectrum
respiratori
viru
detect
appropri
manag
patient
respiratori
viru
infect
requir
rapid
identif
etiolog
agent
nat
emerg
prefer
gold
standard
approach
diagnosi
respiratori
infect
either
adjunct
test
replac
lee
et
al
nat
easili
compromis
sampl
qualiti
time
collect
relat
onset
symptom
also
benefit
laboratori
safeti
turnaround
time
diagnost
test
undertaken
without
prior
cultur
unknown
organ
diagnosi
respiratori
infect
complex
wide
rang
potenti
pathogen
present
clinic
symptom
nat
assist
process
picornavirus
rhinovirus
enterovirus
coronavirus
long
recogn
caus
respiratori
symptom
identifi
effici
use
standard
virolog
approach
undertaken
major
laboratori
detect
import
virus
increasingli
undertaken
use
nat
allow
full
realiz
like
role
virus
respiratori
infect
diseas
garbino
et
al
jartti
et
al
monto
vallet
et
al
arden
et
al
esposito
et
al
jacqu
et
al
kusel
et
al
lee
et
al
loen
et
al
manoha
et
al
recent
year
mani
new
respiratori
viru
pathogen
identifi
import
test
virus
includ
respiratori
viru
test
algorithm
prove
effici
inclus
least
nat
diagnost
test
repertoir
although
antigen
cultur
method
avail
virus
see
articl
ginocchio
supplement
human
metapneumoviru
hmpv
increasingli
recogn
import
viral
pathogen
young
elderli
bosi
et
al
sivaprakasam
et
al
van
den
hoogen
human
bocaviru
hbov
although
often
present
copathogen
associ
signific
diseas
particularli
young
arden
et
al
arnold
et
al
bastien
et
al
recent
identifi
human
coronavirus
also
evalu
clinic
relev
assess
use
nat
chiu
et
al
kaiser
et
al
woo
et
al
esposito
et
al
gerna
et
al
koetz
et
al
lau
et
al
han
et
al
kupfer
et
al
use
nat
allow
assess
impact
wider
array
potenti
pathogen
respiratori
infect
previous
possibl
targetspecif
multiplex
approach
prove
feasibl
enhanc
broadspectrum
respiratori
viru
diagnosi
review
overview
establish
method
new
procedur
respiratori
viru
nucleic
acid
detect
diagnosi
given
wide
rang
target
signal
amplif
nucleic
acid
amplif
method
could
appli
respiratori
viru
detect
target
amplif
method
advantag
sensit
signal
amplif
latter
may
simpler
less
labori
high
specimen
throughput
review
focus
method
detail
public
use
either
hous
commerciallyavail
assay
respiratori
viru
nucleic
acid
detect
avail
critic
downstream
nucleic
acid
detect
method
qualiti
extract
nucleic
acid
need
purifi
away
inhibitor
case
concentr
sampl
undertaken
extract
procedur
enhanc
clinic
sensit
conveni
eluat
contain
purifi
nucleic
acid
suitabl
dna
rna
amplif
detect
methodolog
although
major
respiratori
viru
target
rna
genom
notabl
except
includ
adv
hbov
import
includ
viral
diagnost
screen
extract
contain
total
nucleic
acid
also
use
analysi
bacteria
may
present
similar
symptom
virus
eg
mycoplasma
pneumonia
chlamydophila
pneumonia
mani
laboratori
autom
extract
concentr
nucleic
acid
purif
critic
util
applic
diagnost
nat
ensur
high
qualiti
reproduc
result
individu
laboratori
tend
evalu
extract
procedur
part
nat
studi
systemat
compar
extract
nucleic
acid
prepar
respiratori
virus
ideal
control
includ
spike
specimen
extract
confirm
step
process
optim
could
modifi
manufactur
nucleic
acid
dingl
et
al
could
make
use
unrel
viru
control
niester
enhanc
sampl
prepar
involv
higher
specimen
throughput
ultim
direct
link
amplif
detect
method
use
robot
primer
probe
design
valid
amplif
rang
viral
respiratori
target
main
problem
lack
capac
throughput
specimen
labori
expens
natur
approach
reli
undertak
mani
individu
nat
singl
sampl
nonselect
amplif
procedur
wide
report
altern
target
specif
amplif
gener
degener
conserv
primer
use
amplifi
identifi
sequenc
variant
new
member
within
viru
famili
sequenceindepend
random
amplif
need
util
unknown
target
viru
discoveri
ambros
clewley
one
disadvantag
use
degener
random
primer
broad
spectrum
amplif
method
amplif
effici
may
reduc
homolog
primer
mix
incorpor
product
design
complex
multiplex
amplif
reaction
requir
good
databas
avail
sequenc
suitabl
softwar
multiplesequ
align
may
beyond
mean
mani
diagnost
laboratori
kitbas
solut
broadspectrum
respiratori
pathogen
diagnosi
incorpor
enhanc
multiplex
pcr
approach
negat
need
individu
laboratori
undertak
complex
design
valid
eg
brunstein
thoma
lee
et
al
li
et
al
mahoni
et
al
pcr
rtpcr
still
common
nucleic
acid
target
amplif
method
use
diagnost
laboratori
partli
procedur
wide
publicis
altern
isotherm
mean
amplifi
target
mani
complex
reaction
diagnost
algorithm
report
tri
repres
widespectrum
potenti
pathogen
caus
respiratori
symptom
despit
wellrecognis
problem
report
larg
studi
use
hous
procedur
multiplex
primer
combin
prove
success
pcr
amplif
coira
et
al
pehlerharrington
et
al
syrmi
et
al
gunson
et
al
weigl
et
al
one
interest
adapt
pcr
amplif
use
touchdown
approach
allow
flexibl
design
primer
set
idea
assay
run
concurr
simultan
amplif
subsequ
detect
respiratori
viru
target
coyl
et
al
approach
avoid
need
complex
multiplex
increas
number
reaction
necessarysampl
nucleic
acid
sequenc
base
amplif
nasba
isotherm
target
amplif
procedur
util
three
enzym
activ
rt
rnaseh
rna
polymeras
order
amplifi
sens
antisens
target
rna
method
appli
success
respiratori
viru
detect
diagnosi
associ
infect
diseas
hibbitt
fox
moor
et
al
landri
et
al
lee
et
al
loen
et
al
moor
et
al
dare
et
al
loopmedi
isotherm
amplif
lamp
origin
develop
rapid
amplif
dna
target
combin
success
revers
transcript
step
rna
respiratori
virus
eg
nagamin
et
al
hong
et
al
method
utilis
target
specif
region
strand
displac
synthesi
result
rapid
isotherm
amplif
target
exampl
amplifi
product
analysi
includ
gelbas
detect
often
seminest
nest
pcr
coira
et
al
coyl
et
al
lamp
hong
et
al
product
autom
fluoresc
capillari
electrophoresi
erdman
et
al
separ
hybridis
product
target
specif
probe
coira
et
al
nest
pcr
first
introduc
enhanc
sensit
specif
pcr
howev
even
experienc
laboratori
problem
amplicon
contamin
use
method
apfalt
et
al
mani
diagnost
laboratori
prefer
method
separ
probebas
hybrid
detect
analysi
amplifi
product
use
realtim
assay
describ
separ
hybrid
method
analysi
amplifi
product
ensur
good
control
specif
analysi
amplifi
product
herald
way
array
base
methodolog
see
use
novel
label
incorpor
amplifi
product
may
facilit
analysi
allow
detect
broader
rang
virus
singl
assay
one
report
methodolog
target
respiratori
virus
use
multiplex
pcr
incorpor
masstag
label
forward
revers
primer
bries
et
al
principl
behind
realtim
assay
amplif
nucleic
acid
target
combin
detect
singl
reaction
need
manipul
amplifi
product
minimis
problem
amplicon
carryov
potenti
fals
posit
reaction
mani
realtim
assay
detect
amplifi
product
utilis
targetspecif
probe
variou
format
chemistri
avail
label
probe
order
discrimin
free
solut
bound
target
multipl
targetspecif
primer
set
use
amplif
ensur
specif
tube
detect
amplifi
product
may
utilis
intercal
dye
turbid
measur
gener
nucleic
acid
detect
procedur
discuss
practic
applic
realtim
pcr
provid
recent
review
gunson
et
al
choic
realtim
amplif
detect
format
depend
laboratori
throughput
level
expertis
avail
number
target
test
fluorescentreport
realtim
assay
limit
spectral
overlap
label
gener
multiplex
realtim
nat
limit
separ
target
detect
thu
tube
amplif
target
combin
specif
check
probe
hybrid
realtim
assay
extrem
use
conveni
one
possibl
caus
respiratori
ill
consid
unfortun
approach
flexibl
need
enhanc
capac
broaden
detect
attempt
build
diagnost
capac
realtim
assay
introduc
multipl
primer
probe
set
multiplex
primer
probe
approach
entir
success
tendenc
reduct
amplif
effici
complex
master
mix
util
one
way
increas
diagnost
capac
separ
nucleic
acid
amplif
away
hybrid
detect
reaction
use
approach
easier
increas
number
target
without
compromis
diagnost
effici
move
away
realtim
assay
could
seen
step
backward
technolog
advantag
multipl
pathogen
detect
singl
assay
thu
latest
diagnost
assay
conveni
individu
realtim
assay
replac
enhanc
capac
separ
amplif
detect
allow
test
base
clinic
present
rather
preconceiv
idea
viral
caus
approach
use
diagnost
set
enhanc
nucleic
acid
amplif
procedur
hybrid
method
format
necessari
microarray
potenti
resolv
complex
amplifi
product
mixtur
array
chip
substrat
may
nylon
membran
glass
silicon
polystyren
microbead
may
variabl
densiti
number
specif
probe
thu
target
queri
probe
design
hybrid
condit
adjust
allow
mismatch
sequenc
detect
product
solidphas
microarray
make
use
convent
hybrid
flowthrough
resequenc
procedur
solidphas
array
format
util
respiratori
viru
detect
analysi
kessler
et
al
coira
et
al
wang
et
al
lin
et
al
suspens
microarray
employ
liquid
phase
bead
conjug
array
technolog
known
luminex
xmap
tm
detect
amplifi
product
suspens
microarray
exhibit
rapid
hybridis
kinet
flexibl
assay
design
format
low
cost
dunbar
new
bead
probe
ad
other
replac
without
reformat
print
new
array
disadvantag
solidphas
array
key
respiratori
target
alreadi
part
earli
releas
commerci
assay
util
multiplex
amplif
detect
use
luminex
system
one
format
multiplex
pcr
product
detect
discrimin
use
templatespecif
probe
conjug
differ
microspher
brunstein
thoma
li
et
al
altern
strategi
multiplex
pcr
use
first
step
follow
primer
direct
target
specif
strand
extens
label
targetspecif
primer
use
label
reaction
incorpor
uniqu
captur
sequenc
captur
sequenc
use
detect
amplifi
product
univers
suspens
microarray
lee
et
al
mahoni
et
al
rvp
assay
luminex
molecular
diagnost
describ
detail
section
review
supplement
summari
main
advantag
refer
nat
enhanc
detect
analysi
respiratori
virus
given
tabl
major
report
studi
use
nat
util
individu
small
multiplex
assay
target
import
respiratori
viru
target
influenza
viru
ifv
b
parainfluenza
virus
piv
adenovirus
adv
respiratori
syncyti
viru
rsv
mani
feasibl
studi
confirm
nat
improv
detect
potenti
pathogen
lower
respiratori
tract
specimen
well
respiratori
swab
even
altern
method
dfa
cultur
avail
hibbitt
fox
moor
et
al
lee
et
al
case
respiratori
adenovirus
detect
dfa
known
particularli
poor
illustr
coyl
et
al
although
cultur
quit
sensit
detect
adv
shorter
turnaround
time
diagnosi
nat
ensur
appropri
earli
manag
employ
infect
prevent
control
procedur
vulner
eg
immunocompromis
individu
well
differenti
design
serotyp
epidemiolog
studi
pehlerharrington
et
al
vabret
et
al
mani
laboratori
retain
use
dfa
method
rapid
analysi
respiratori
sampl
particular
triag
cohort
vulner
hospit
patient
yield
dfa
good
season
peak
rsv
ifv
especi
appropri
taken
nasopharyng
np
sampl
avail
children
tend
shed
larg
amount
viru
compar
adult
diagnost
yield
dfa
nonnp
sampl
type
target
ifva
ifvb
piv
rsv
much
less
tabl
give
result
analysi
dfa
neg
np
sampl
use
sensit
realtim
nat
ifva
ifvb
rsv
nat
methodolog
previous
publish
lee
et
al
enhanc
sensit
nat
dfa
critic
target
clearli
demonstr
despit
fact
np
sampl
includ
analysi
enhanc
pick
piv
nat
particularli
obviou
although
due
partli
lack
dfa
test
reagent
known
caus
respiratori
infect
vast
major
dfa
neg
piv
nat
posit
dfa
test
use
ifva
rsv
even
target
signific
number
posit
miss
procedur
alon
use
decis
patient
manag
infect
prevent
control
antigen
culturebas
procedur
diagnost
util
detect
ifva
ifvb
rsv
adv
virus
miss
nat
includ
diagnost
algorithm
shown
tabl
nat
wellestablish
advantag
enhanc
detect
picornavirus
enterovirus
rhinovirus
coronavirus
virus
long
acknowledg
import
caus
respiratori
infect
diseas
identifi
easili
antigen
cultur
procedur
practic
applic
multiplex
pcr
amplif
novel
masstag
label
led
identif
previous
unidentifi
rhinovirus
caus
nonspecif
respiratori
ill
lamson
et
al
analysi
recentlyidentifi
coronavirus
use
nat
confirm
although
seem
found
commonli
chiu
et
al
kaiser
et
al
esposito
et
al
gerna
et
al
koetz
et
al
han
et
al
also
associ
sever
diseas
case
woo
et
al
lau
et
al
kupfer
et
al
epidemiolog
studi
hbov
requir
use
nat
viru
recogn
caus
acut
respiratori
viru
infect
either
alon
copathogen
young
children
arden
et
al
arnold
et
al
bastien
et
al
et
al
use
nat
led
identif
respiratori
viru
coinfect
previous
recognis
use
lesssensit
antigen
cultur
method
individu
nat
util
multipl
infect
identifi
frequent
use
realtim
multiplex
reaction
may
lead
competit
amplif
detect
tabl
enhanc
detect
respiratori
virus
use
nat
viru
target
nat
enhanc
compar
antigen
cultur
procedur
exampl
refer
illustr
nat
diagnost
enhanc
ifv
improv
sensit
rapid
subtyp
strain
analysi
avail
nucleic
acid
faster
turnaround
cultur
infecti
viru
amplifi
import
safeti
factor
compar
cultur
pandem
avian
virus
erdman
et
al
coyl
et
al
jen
et
al
moor
et
al
syrmi
et
al
weinberg
et
al
lee
et
al
van
de
pol
et
al
wang
et
al
li
et
al
mahoni
et
al
ifv
b
improv
sensit
faster
turnaround
cultur
erdman
et
al
coyl
et
al
jen
et
al
weinberg
et
al
rsv
improv
sensit
faster
turnaround
cultur
van
elden
et
al
erdman
et
al
jen
et
al
garbino
et
al
syrmi
et
al
weinberg
et
al
kusel
et
al
lee
et
al
moor
et
al
van
de
pol
et
al
lee
et
al
li
et
al
piv
improv
sensit
faster
turnaround
cultur
van
elden
et
al
erdman
et
al
coira
et
al
coyl
et
al
jen
et
al
syrmi
et
al
weinberg
et
al
lee
et
al
piv
detect
routin
except
nat
coira
et
al
lee
et
al
hmpv
improv
sensit
faster
turnaround
cultur
jen
et
al
koetz
et
al
lee
et
al
dare
et
al
lee
et
al
hbov
detect
routin
except
nat
arden
et
al
arnold
et
al
bastien
et
al
adv
improv
sensit
compar
antigen
detect
faster
turnaround
cultur
coyl
et
al
jen
et
al
pehlerharrington
et
al
syrmi
et
al
vabret
et
al
arden
et
al
lee
et
al
lee
et
al
li
et
al
picornavirus
picornavirus
detect
routin
nat
faster
turnaround
better
sensit
cultur
rhinovirus
enterovirus
van
elden
et
al
coira
et
al
garbino
et
al
jartti
et
al
jen
et
al
landri
et
al
arden
et
al
jacqu
et
al
kusel
et
al
lamson
et
al
lee
et
al
van
de
pol
et
al
lee
et
al
coronavirus
coronavirus
detect
routin
nat
faster
turnaround
better
sensit
cultur
virus
sar
coronaviru
infecti
viru
amplifi
import
safeti
factor
compar
cultur
sar
jen
et
al
vallet
et
al
chiu
et
al
kaiser
et
al
arden
et
al
esposito
et
al
gerna
et
al
koetz
et
al
lau
et
al
lee
et
al
han
et
al
lee
et
al
sampl
nasopharyng
sampl
swab
aspir
collect
test
target
result
underestim
coinfect
rate
case
coinfect
link
sever
ill
eg
coronavirus
gerna
et
al
paramyxovirus
rsv
hmpv
sempl
et
al
hypothesi
sever
symptom
occur
addit
effect
multipl
viru
infect
controversi
warrant
studi
despit
demonstr
enhanc
sensit
nat
delay
diagnost
implement
assay
reason
includ
technic
complex
cost
lack
proper
valid
standard
assay
particular
problem
note
profici
studi
use
nat
diagnost
laboratori
undertaken
show
fals
posit
fals
neg
may
report
apfalt
et
al
templeton
et
al
one
studi
util
solidphas
microarray
hybrid
randomli
amplifi
pcr
product
respiratori
cultur
clinic
sampl
demonstr
compar
result
altern
cultur
individu
pcr
method
palacio
et
al
potenti
use
flowthrough
array
procedur
detect
type
influenza
singl
reaction
also
suggest
kessler
et
al
applic
resequenc
array
clinic
studi
demonstr
correct
sequenc
strain
identif
use
array
target
gene
respiratori
pathogen
lin
et
al
particular
applic
resequenc
array
track
influenza
genet
variat
confirm
util
approach
inform
vaccin
develop
wang
et
al
one
disadvantag
use
resequenc
array
molecular
epidemiolog
studi
howev
need
redesign
compon
array
regularli
reflect
rna
viru
sequenc
variat
evalu
suspens
microarray
approach
retrospect
analysi
respiratori
specimen
confirm
good
sensit
specif
compar
antigen
cultur
base
procedur
describ
detail
articl
review
supplement
nat
advantag
enhanc
sensit
compar
mani
antigen
culturebas
assay
short
turnaround
time
especi
compar
tradit
cultur
sampl
contain
possibl
level
pathogen
also
safeti
logist
advantag
use
nat
cultur
sinc
sampl
inactiv
prior
analysi
test
level
environ
howev
broad
rang
pathogen
caus
similar
respiratori
symptomolog
make
difficult
appli
individu
monoplex
small
multiplex
nat
comprehens
respiratori
diagnosi
approach
cost
prohibit
may
even
possibl
specimen
quantiti
limit
clinicallyrelev
respiratori
pathogen
identifi
technolog
chang
nat
perform
necessari
meet
ever
expand
diagnost
need
technolog
enhanc
valid
requir
diagnost
base
nat
consid
practic
outbreak
situat
caus
agent
may
known
respiratori
viru
amplif
detect
procedur
util
microarray
develop
evalu
outsid
research
laboratori
becom
access
diagnost
laboratori
develop
evalu
method
prospect
diagnost
studi
necessari
sensit
specif
assay
paramet
need
compar
altern
format
type
assay
particularli
individu
nat
target
target
also
need
incorpor
valid
novel
virus
pathogen
identifi
base
need
pandem
prepared
evalu
suspens
microarray
nat
complet
util
highand
lowthroughput
diagnost
laboratori
cost
implic
appli
technolog
defin
like
technolog
base
current
avail
commerci
assay
similar
method
develop
becom
wide
util
respiratori
viru
diagnosi
approv
regul
assay
appropri
agenc
concurr
avail
suitabl
qualiti
control
profici
panel
materi
establish
amplif
method
combin
arraybas
detect
next
gold
standard
respiratori
viru
diagnosi
nucleic
acid
amplif
test
modifi
format
make
use
enhanc
amplif
arraybas
hybrid
potenti
impact
diagnosi
identif
novel
virus
care
must
taken
howev
consid
qualiti
control
issu
learn
problem
note
use
nonstandard
individu
nat
ideal
next
rang
respiratori
viru
diagnost
util
valid
fda
health
canada
ce
mark
assay
provid
commerci
compani
avail
suitabl
profici
panel
respiratori
virus
critic
ensur
standard
qualiti
control
new
diagnost
procedur
none
declar
